Monitoring Drug Therapy

Dr. Mackin is currently Professor and Head of the Department of Clinical Sciences at Mississippi State University. Andrew is a 1983 graduate of Murdoch University in Western Australia, and after graduation completed an internship and residency in small animal medicine at the University of Melbourne, followed by an internal medicine residency at the Ontario Veterinary College.  Andrew became a Fellow of the ANZCVS in 1993, and a Diplomate of the American College of Veterinary Internal Medicine in 1994. Andrew has a clinical and research focus on hematology, hemostasis, immunosuppressive therapy and transfusion medicine.  In 2006, he received the Carl Norden-Pfizer Distinguished Teacher Award and, in 2010, the MSU-CVM Dean's Pegasus Award.

Dr. Carpentier has been practicing as a veterinary neurologist in Minnesota since 2016. She is the founder of Minnesota Veterinary Neurology, a brand-new, state-of-the-art specialty hospital dedicated exclusively to neurologic care. Dr. Carpentier enjoys all aspects of veterinary neurology, from the medical management of epileptic patients to optimizing quality of life, to advanced neurosurgical procedures that help patients regain mobility and live pain-free lives. She is passionate about education and enjoys speaking on a wide range of neurology-related topics. Her speaking engagements have taken her across the country, and she is a regular speaker for VETgirl.

Dr. Brookshire is a Veterinary Epidemiologist and Associate Clinical Professor at Mississippi State University College of Veterinary Medicine. He worked in small animal general practice for five years before returning to academia in 2015. He is board certified in Veterinary Preventive Medicine, Veterinary Epidemiology, and by ABVP in Canine and Feline Practice. His research, clinical, and teaching interests include antimicrobial stewardship, antimicrobial resistance, epidemiology, One Health, pharmacology, and biosecurity. 

Dr. Foster completed an internal medicine residency at the University of Wisconsin and later became a diplomat of the American College of Veterinary Clinical Pharmacology and the American College of Veterinary Nephrology-Urology. After several years in academia, he now runs the Nephrology & Urology and Extracorporeal Therapies services at Friendship Hospital for Animals in Washington, DC. Dr. Foster’s research interests include nontraditional uses of extracorporeal blood purification, glomerulonephritis, and drug pharmacokinetics in patients with kidney disease. He has lectured internationally on these subjects and has published numerous manuscripts and book chapters in nephrology and urology. He is a past-president of the American Society of Veterinary Nephrology and Urology, a current board member of the International Renal Interest Society, and the President-elect and founding member of the American College of Veterinary Nephrology and Urology.
 

Dr. Langlois is a tenured professor and clinician scientist at the Michigan State University College of Veterinary Medicine.  He is originally from Baton Rouge, LA, and he received his DVM from Louisiana State University in 2009.  He then completed a 1-year internship at The Ohio State University which was followed by an internal medicine residency at Michigan State University.  He obtained board certification from the American College of Veterinary Internal Medicine (ACVIM) in 2013, and he has been an MSU faculty member since that time.  Daniel has strong clinical, teaching, and research interests in companion animal endocrinology and canine hepatology.  He is an active clinical researcher, frequently lectures at continuing education events and conferences, is a scientific review board member for JAVMA, and routinely serves as an ad-hoc reviewer for various other veterinary journals.   
 

Dr. Lathan earned her VMD from the University of Pennsylvania, then completed an internship at Mississippi State University and a small animal internal medicine residency at Purdue University. She taught at Mississippi State for 16 years before moving to LSU. Dr. Lathan specializes in endocrinology, specifically adrenal function testing, diabetes mellitus, and the mitigation of side effects of glucocorticoids. She is a past-president of the Society for Comparative Endocrinology.

Dr. Mealey is a Washington State University Regents Professor and directs the Program in Individualized Medicine. She pioneered veterinary pharmacogenetics holding patents that dramatically improve canine and feline drug safety. She has authored over 100 peer-reviewed publications, received numerous awards and is a fellow of the U.S. National Academy of Inventors, Washington State Academy of Sciences, and the American Association for the Advancement of Science.

Dr. Papich is a Professor of Clinical Pharmacology and the Burroughs Wellcome Fund Professorship in Veterinary Pharmacology at North Carolina State University. He is the Supervisor of the Clinical Pharmacology Laboratory in the College of Veterinary Medicine at North Carolina State University. He is a diplomate in the American College of Veterinary Clinical Pharmacology (ACVCP), and has served as president of ACVCP. He has served on various Expert Committees: the Council of Experts, and Chairman for the Veterinary Drugs Expert Committee for the United States Pharmacopeia (USP) and is a current member of the USP Expert Committee. He is a member of the AVMA Committee on Antibiotics (CoA). He is a past Chairholder of the Clinical Laboratory Standards Institute (CLSI) Veterinary Antimicrobial Susceptibility Testing subcommittee (VAST) He has taught veterinary pharmacology for over 30 years. He has authored/edited nine books on veterinary pharmacology and is one of the editors of the 9th and 10th editions of Veterinary Pharmacology and Therapeutics. He is author or co-author of over 300 research papers published in refereed journals and has authored over 140 book chapters, and review papers (h-index 66). He has several awards including the Zoetis Distinguished Veterinary Teacher Award and the Faculty Award presented to the outstanding teacher by veterinary classes. He was also awarded the Pfizer Award for Research Excellence, the Excellence in Consensus Management by the Clinical and Laboratory Standards Institute (CLSI), the Lloyd E. Davis Award by the AAVPT, the Distinguished Fellow Award from AAVPT, and the Huffman Leadership Award from NC State University. He has also delivered hundreds of presentations on veterinary pharmacology at national and international veterinary meetings, conferences and symposia.

Dr. Quimby is board certified in small animal internal medicine and completed a PhD studying feline CKD and was on faculty at Colorado State University until 2017. She is now a professor of small animal internal medicine at the Ohio State University. Current research areas include the study of renal pathophysiology, novel treatment strategies and evidence-based supportive care strategies. She has an interest in feline clinical pharmacology focusing on improving supportive care and quality of life in cats with CKD. Dr. Quimby has received the International Renal Interest Society Award and the AVMF/Winn Feline Foundation Research Award for her contributions to nephrology and feline medicine. In 2021 she was selected to serve on the IRIS board.